Immunoreactivity of α-melanocyte-stimulating hormone, adrenocorticotrophic hormone and β-endorphin in cutaneous malignant melanoma and benign melanocytic naevi

British Journal of Dermatology

Volumn 138, Issue 6, 1998, Pages 981-985

  Nagahama, M ^a   Funasaka, Y ^a   Fernandez Frez, M L ^a   Ohashi, A ^a   Chakraborty, A K ^b   Ueda, M ^a   Ichihashi, M ^a  

^a KOBE UNIVERSITY   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; CORTICOTROPIN; HORMONE ANTIBODY; MELANOCORTIN RECEPTOR; PROOPIOMELANOCORTIN;

ARTICLE; CANCER GROWTH; DISEASE ASSOCIATION; GENE EXPRESSION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MELANOCYTIC NEVUS; MELANOMA; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; BETA-ENDORPHIN; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOCYTE-STIMULATING HORMONES; MELANOMA; NEVUS, PIGMENTED; PRO-OPIOMELANOCORTIN; SKIN; SKIN NEOPLASMS;

EID: 0031748388     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02263.x     Document Type: Article

References (27)

1. Slominski A. POMC gene expression in mouse and hamster melanoma cells. FEBS Lett 1991; 291: 165-8.
2. Ghanem G, Verstegen J, Libert A et al. Alpha-melanocyte-stimulating hormone immunoreactivity in human melanoma metastases extracts. Pig Cell Res 1989; 2: 519-23.
3. Ghanem G, Loir B, Hadley M et al. Partial characterization of IR-α-MSH peptides found in melanoma tumors. Peptides 1992; 15: 989-94.
4. Chakraborty AK, Funasaka Y, Slominski A et al. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by UVB. Biochim Biophys Acta 1996; 1313: 130-8.
5. Bregman MD, Abdel-Malek ZA, Meyskens FL Jr. Anchorage-independent growth of murine melanoma in serum-less media is dependent on insulin or melanocyte-stimulating hormone. Exp Cell Res 1985; 157: 419-28.
6. Sheppard JR, Koestler TP, Corwin SP et al. Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones. Nature 1984; 308: 544-7.
7. Benett DC, Dexter TJ, Ormerod EJ et al. Increased experimental metastatic capacity of a murine melanoma following induction of differentiation. Cancer Res 1986; 46: 3239-44.
8. Benett DC, Holmes A, Devlin L et al. Experimental metastasis and differentiation of murine melanoma cells: actions and interactions of factors affecting different intracellular signalling pathways. Clin Exp Metastasis 1994; 12: 385-97.
9. Tatro JB, Atkins M, Mier JW et al. Melanotropin receptors demonstrated in situ in human melanoma. J Clin Invest 1990; 85: 1825-32.
10. Ghanem G, Lienard D, Hanson P et al. Increased serum alpha-melanocyte stimulating hormone (alpha-MSH) in human malignant melanoma. Eur J Cancer Clin Oncol 1986; 22: 535-6.
11. 3-melanocyte stimulating hormone expression in cutaneous malignant melanoma of nodular type. J Dermatol Sci 1995; 10: 203-12.
12. Slominski A, Paus R, Wortsman J. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol 1993; 93: C1-6.
13. Slominski A, Wortsman J, Mazurkiewicz JE et al. Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 1993; 122: 658-66.
14. Ohashi A, Funasaka Y, Ueda M et al. c-KIT receptor expression in cutaneous malignant melanoma and benign melanocytic nevi. Melanoma Res 1996; 6: 25-30.
15. Lunec J, Pieron C, Thody AJ. MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma. Melanoma Res 1992; 2: 5-12.
16. Buffey J, Thody AJ, Bleehen SS, Mac Neil S. α-Melanocyte-stimulating hormone stimulates protein kinase C activity in murine B16 melanoma. J Endocrinol 1992; 133: 333-40.
17. Hunt G, Donatien P, Cresswell JE, Thody AJ. The effect of α-MSH on the attachment of human melanocytes to laminin and fibronectin. Evidence for specific α-MSH receptors on these cells. Ann NY Acad Sci 1993; 680: 549-51.
18. Luger TA, Schauer E, Trautinger F et al. Production of immunosuppressing melanotropins by human keratinocytes. Ann NY Acad Sci 1993; 680: 567-70.
19. Bhardwaj RS, Schwarz A, Mahnke K et al. Pro-opiomelanocortin-derived-peptides induce IL-10 production in human monocytes. J Immunol 1996; 156: 2517-21.
20. Shimizu T, Streilein JW. Influence of alpha-melanocyte stimulating hormone on induction of contact hypersensitivity and tolerance. J Dermatol Sci 1994; 8: 187-93.
21. Valverde P, Healy E, Sikkink S et al. The Asp84Glu variant of the melanocortin receptor (MC1R) is associated with melanoma. Hum Mol Genet 1996; 5: 1663-6.
22. Bhardwaj RS, Luger TA. Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis. Arch Dermatol Res 1994; 287: 85-90.
23. Mountjoy KG, Robbins LS, Mortrud MT et al. The cloning of a family of genes that encode the melanocortin receptors. Science 1992; 257: 1248-51.
24. Chhajlani V, Wikkberg JES. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 1992; 309: 417-20.
25. Suzuki I, Cone RD, Im S et al. Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 1996; 137: 1627-33.
26. Slominski A, Ermak G, Mihm R. ACTH receptor. CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab 1996; 81: 2746-9.
27. Slominski A, Ermak G, Hwang J et al. Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett 1995; 374: 113-16.